Press release
Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Global Outlook, Trends, and Growth Forecast 2025-2034
Get a free sample report: https://shorturl.at/6RZpX
This article offers a comprehensive analysis of the NSAIDs market including size and share, market dynamics, key trends, growth drivers, opportunities, challenges, competitive landscape, and frequently asked questions.
Overview of the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications globally, prescribed for managing inflammation, pain, and fever. They function by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin production responsible for pain and inflammation.
NSAIDs are preferred over opioids due to their lower risk of addiction, making them a cornerstone in the treatment of musculoskeletal disorders, arthritis, menstrual pain, and postoperative recovery. The growing awareness about opioid misuse has accelerated a shift towards safer alternatives like NSAIDs, further expanding market penetration.
NSAIDs Market Size and Share Analysis
The global NSAIDs market was valued at USD 21.70 billion in 2024. The growth is largely fueled by:
Rising incidence of chronic conditions like osteoarthritis and rheumatoid arthritis
Increasing aging population in developed and emerging countries
Rising preference for OTC (over-the-counter) drugs
Escalating sports and exercise-related injuries
The market is projected to grow at a CAGR of 5.40% from 2025 to 2034, reaching USD 36.72 billion by 2034. North America currently dominates the global market, followed closely by Europe and the Asia-Pacific region. The Asia-Pacific market is expected to witness the fastest growth due to increasing healthcare access, rising awareness, and increasing healthcare expenditure.
Read full report with table of content: https://shorturl.at/dfiRo
Market Dynamics and Emerging Trends
Key Market Drivers
Shift from Opioid Analgesics: The opioid crisis in North America and rising global awareness has led healthcare providers to prefer NSAIDs over opioids.
Rising Incidence of Chronic Disorders: A growing geriatric population is contributing to an increase in diseases such as arthritis, back pain, and other inflammatory conditions.
Expanding OTC Availability: The availability of NSAIDs without a prescription has contributed to their increasing use worldwide.
Growing Awareness of Drug Safety and Side Effects: Enhanced awareness among patients and clinicians regarding the side effects of pain medications, including NSAIDs, has resulted in more regulated and informed usage.
Market Restraints
Gastrointestinal and Cardiovascular Risks: Long-term use of NSAIDs can lead to gastrointestinal ulcers and cardiovascular issues, impacting their adoption.
Patent Expirations and Generic Competition: Many NSAIDs have gone off-patent, which has increased generic competition, lowering the average selling price of these drugs.
Notable Market Trends
Development of COX-2 Selective Inhibitors: These NSAIDs reduce gastrointestinal side effects and are gaining popularity.
Increasing Use in Veterinary Medicine: NSAIDs are being increasingly adopted for pain management in pets and livestock.
Technological Advancements in Drug Delivery: Innovative delivery systems such as topical gels, patches, and sustained-release formulations are improving patient compliance.
Growth Forecast and Regional Insights
The NSAIDs market is anticipated to grow significantly over the forecast period, driven by both prescription and OTC sales. Region-wise insights include:
North America: Leading due to high awareness, advanced healthcare infrastructure, and rising arthritis prevalence.
Europe: Benefiting from the aging population and high rates of orthopedic and autoimmune disorders.
Asia-Pacific: Emerging as the fastest-growing market due to improving healthcare access, population growth, and lifestyle-related disorders.
Government initiatives to promote non-opioid treatments and the rising number of surgeries and trauma cases further support global NSAID market growth.
Market Opportunities
Product Innovation and Extended Drug Release Formulations: Pharmaceutical companies are innovating extended-release NSAIDs to enhance efficacy and reduce side effects.
Rising Sports Injuries and Active Lifestyles: With more individuals adopting fitness routines and sports, the demand for short-term pain relief is increasing.
Growing Telemedicine and E-Pharmacy Adoption: Especially in emerging markets, this trend boosts access to OTC NSAIDs.
Challenges Facing the NSAIDs Market
Despite strong growth prospects, the NSAIDs market faces several challenges:
Adverse Side Effects: Chronic use of NSAIDs is linked with renal impairment, cardiovascular risks, and gastrointestinal issues.
Regulatory Compliance: Stringent regulatory policies related to drug safety and labeling can delay product approvals.
Price Pressure: Increasing generic competition results in price erosion, especially in emerging markets.
Recent Developments in the NSAIDs Market
Pfizer has been investing in digital platforms to expand its reach in the OTC segment.
Bayer AG launched a new formulation of Aleve designed for extended relief.
Johnson & Johnson has focused on educational campaigns to promote safe NSAID use.
Amgen and Novartis are researching COX-2 selective NSAIDs with improved safety profiles.
Sanofi India Limited has ramped up its distribution channels to penetrate rural healthcare markets.
Competitive Landscape and Key Players
The NSAIDs market is moderately fragmented with a mix of established pharmaceutical giants and regional players. Companies are engaged in strategies such as partnerships, product launches, acquisitions, and R&D investments to expand their market presence.
Key Companies in the NSAIDs Market
Assertio Holdings, Inc.: Specializes in neurology and inflammation treatments, including advanced NSAID products.
Bayer AG: Manufacturer of globally popular NSAID brands like Aleve.
Amgen Inc.: Focuses on developing biologics and has a growing presence in anti-inflammatory therapeutics.
Lion Corporation: A key player in the Asian OTC NSAIDs space.
Dr. Reddy's Laboratories Ltd.: Offers a wide portfolio of generic NSAIDs across global markets.
Novartis AG: Active in developing new-generation NSAIDs and pain relievers.
Pfizer Inc.: Market leader in OTC and prescription NSAIDs with a strong global distribution network.
Johnson & Johnson Private Limited: Operates in both consumer health and pharmaceuticals, with widely-used NSAIDs.
GlaxoSmithKline plc: Known for Voltaren (diclofenac), a leading topical NSAID.
Sanofi India Limited: Expanding NSAID offerings through both prescription and OTC channels.
Frequently Asked Questions (FAQs)
What are NSAIDs?
NSAIDs are non-steroidal anti-inflammatory drugs used to reduce inflammation, pain, and fever. Common NSAIDs include ibuprofen, naproxen, diclofenac, and aspirin.
What is driving the growth of the NSAIDs market?
Key growth drivers include the shift away from opioids, the high prevalence of chronic pain, the rise in geriatric population, and growing awareness of NSAID safety and efficacy.
What are the risks associated with NSAID usage?
Long-term or high-dose NSAID use can lead to gastrointestinal bleeding, kidney damage, and cardiovascular complications.
Which regions dominate the NSAIDs market?
North America and Europe currently dominate the market, while Asia-Pacific is expected to grow at the fastest rate during the forecast period.
Who are the major players in the NSAIDs market?
Leading companies include Pfizer, Bayer, Johnson & Johnson, Novartis, Sanofi, GSK, Dr. Reddy's, and Amgen.
What is the market outlook for 2034?
The market is expected to reach USD 36.72 billion by 2034, growing at a CAGR of 5.40% from 2025, driven by innovation, increasing healthcare access, and rising disease burden.
The Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market is poised for steady growth over the next decade, powered by evolving healthcare preferences, increased chronic disease prevalence, and global efforts to curb opioid dependency. While challenges such as adverse effects and regulatory hurdles remain, innovation in drug formulations, broader OTC access, and market penetration into developing regions will continue to unlock opportunities for market players. Companies that focus on patient safety, education, and product innovation will likely lead in this evolving landscape.
For a deeper understanding and strategic insights into the NSAIDs market, detailed forecasts, and company profiles, refer to industry resources like Expert Market Research.
Find More Report:
Phenylketnuria (PKU) Drug Pipeline Analysis Report: https://shorturl.at/VQAey
Colorectal Cancer Drug Pipeline Analysis: https://shorturl.at/M4Dte
Head and Neck Cancer Drug Pipeline Analysis: https://shorturl.at/JwTqx
Oncolytic Virus Cancer Therapy Pipeline Analysis: https://shorturl.at/al8AU
Vitiligo Drug Pipeline Analysis: https://shorturl.at/g2uYx
Media Contact:
Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Global Outlook, Trends, and Growth Forecast 2025-2034 here
News-ID: 4069293 • Views: …
More Releases from Expert Market Research
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for NSAID
NSAID API Market, Strategic Developments, Demand Surge in Chronic Pain Treatment …
Overview of the NSAID API Market
The global NSAID (Nonsteroidal Anti-inflammatory Drug) Active Pharmaceutical Ingredients (API) market is witnessing significant momentum, primarily driven by increasing incidences of chronic pain, arthritis, and inflammatory diseases worldwide. These APIs serve as the core components in formulating a wide range of prescription and over-the-counter analgesic medications. As the burden of non-communicable diseases rises globally, especially among the aging population, the demand for NSAID-based treatments has…
NSAID Ophthalmic Drugs Latest Market Analysis Report 2025
On Mar 12, 2025, Global Info Research released a research report titled "Global NSAID Ophthalmic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the NSAID Ophthalmic Drugs market from 2020 to 2031. Including the market size and development trends of NSAID Ophthalmic Drugs Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it…
Global NSAID Ophthalmic Drugs Market Analysis By Major Manufacturers and Competi …
Globally, NSAID Ophthalmic Drugs key manufacturers include AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer and Sun Pharmaceutical Industries, etc. AbbVie, Bausch Health, Bayer are top 3 players and held % sales share in total in 2022
Global NSAID Ophthalmic Drugs Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of…
Non-steroidal Anti-inflammatory Drugs (NSAID) Market Will Escalate Rapidly In Th …
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2022 research report initially provides a basic overview of the Market that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Request sample pages of this research study at -
https://www.theinsightpartners.com/sample/TIPRE00004421/?utm_source=OpenPR&utm_medium=10366
The non-steroidal anti-inflammatory drugs are a type of pain reliever that help to reduce inflammation and lower fevers. The NSAIDs are the most prescribed medications, which are…
Global NSAID API Market Size,Depth Research Report 2022-2028|Novartis, Pfizer, B …
Global Market For NSAID API Estimated At US$ Million In The Year 2022, Is Projected To Reach A Revised Size Of US$ Million By 2028, Growing At A CAGR Of % During The Forecast Period 2022-2028.
Los Angeles, United States October 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global NSAID API market. It sheds light on how the…
IoT (Internet Of Medical Things) To Be The Buzzword For NSAID API Market
An Active Pharmaceutical Ingredient (API) is a bulk drug used as an ingredient in a dosage form. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that group together drugs that provide analgesic (analgesic) and antipyretic (reducing fever) effects and, at high doses, anti-inflammatory effects.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17038
The term nonsteroidal distinguishes these drugs from steroids, which have similar eicosanoid inhibitory, anti-inflammatory properties, among a wide…
